Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
MESO 2019
IASLC 2019 Mesothelioma Meeting
July 10 – 12, 2019, New York, New York
Presentation Date(s):- July 10 – 12, 2019
- Total Presentations: 117
-
+
Keynote Lecture
- Type: Session
- Track:
- Presentations: 1
- Slides Available
- Moderators:Valerie Rusch
- Coordinates: 7/10/2019, 19:00 - 20:00,
-
+
Keynote Lecture (Slides Available)
19:00 - 20:00 | Author(s): Valerie Rusch
- Abstract
No abstract available for this presentation
-
+
FGFR/PDGFR/Angiogenesis Session
- Type: Session
- Track:
- Presentations: 12
- Slides Available
- Moderators:Giorgio Scagliotti
- Coordinates: 7/11/2019, 07:45 - 08:45, Westin New York at Times Square
-
+
Bevacizumab MAPS I (Slides Available)
07:45 - 07:50 | Author(s): Gerard Zalcman
- Abstract
No abstract available for this presentation
-
+
LUME-Meso Nintedanib (Slides Available)
07:50 - 07:55 | Author(s): Giorgio Scagliotti
- Abstract
No abstract available for this presentation
-
+
S0905 Cediranib (Slides Available)
07:55 - 08:00 | Author(s): Anne Tsao
- Abstract
No abstract available for this presentation
-
+
Nintedanib Salvage (Slides Available)
08:00 - 08:05 | Author(s): Antoinette Wozniak
- Abstract
No abstract available for this presentation
-
+
Nintedanib Maintenance (Slides Available)
08:05 - 08:10 | Author(s): Sanjay Popat
- Abstract
No abstract available for this presentation
-
+
Imatinib Mesylate (Slides Available)
08:10 - 08:15 | Author(s): Tom Stinchcombe
- Abstract
No abstract available for this presentation
-
+
Carotuximab (TRC105) (Slides Available)
08:15 - 08:20 | Author(s): Melina Marmarelis
- Abstract
No abstract available for this presentation
-
+
FGFR Inhibitors (Pemigatinib) (Slides Available)
08:20 - 08:25 | Author(s): Matthew Gubens
- Abstract
No abstract available for this presentation
-
+
NGR019 (NGR-hTNF) (Slides Available)
08:25 - 08:30 | Author(s): Diego Cortinovis
- Abstract
No abstract available for this presentation
-
+
Bevacizumab-Atezolizumab (Slides Available)
08:30 - 08:35 | Author(s): Anne Tsao
- Abstract
No abstract available for this presentation
-
+
Nintedanib-Pembrolizumab (Slides Available)
08:35 - 08:40 | Author(s): Arnaud Scherpereel
- Abstract
No abstract available for this presentation
-
+
(BEAT) Carbo-pem-bev-atezo (Slides Available)
08:40 - 08:45 | Author(s): Sanjay Popat
- Abstract
No abstract available for this presentation
-
+
Immune Checkpoint Inhibitors as Single Agents
- Type: Session
- Track:
- Presentations: 8
- Slides Available
- Moderators:Bruce Robinson
- Coordinates: 7/11/2019, 09:00 - 09:45, Westin New York at Times Square
-
+
Science of Checkpoint Inhibitors (Slides Available)
09:00 - 09:10 | Author(s): Paul Baas
- Abstract
No abstract available for this presentation
-
+
Pembrolizumab (Slides Available)
09:10 - 09:15 | Author(s): Corey Langer
- Abstract
No abstract available for this presentation
-
+
Nivolumab (Slides Available)
09:15 - 09:20 | Author(s): Matthew Gubens
- Abstract
No abstract available for this presentation
-
+
Nivolumab-Japan MERIT Trial (Slides Available)
09:20 - 09:25 | Author(s): Yasushi Goto
- Abstract
No abstract available for this presentation
-
+
Atezolizumab (Slides Available)
09:25 - 09:30 | Author(s): Aaron Mansfield
- Abstract
No abstract available for this presentation
-
+
Durvalumab (Slides Available)
09:30 - 09:35 | Author(s): Anna Nowak
- Abstract
No abstract available for this presentation
-
+
Avelumab (Slides Available)
09:35 - 09:40 | Author(s): Melina Marmarelis
- Abstract
No abstract available for this presentation
-
+
Tremelimumab (Slides Available)
09:40 - 09:45 | Author(s): Luana Calabr
- Abstract
No abstract available for this presentation
-
+
DEBATE 1: PDL1 Tumor Mutation Burden Testing Before Immunotherapy
- Type: Session
- Track:
- Presentations: 2
- Slides Available
- Moderators:Fred Hirsch
- Coordinates: 7/11/2019, 10:05 - 10:35, Westin New York at Times Square
-
+
DEBATE 1: PDL1 Testing and Tumor Mutation Burden Testing SHOULD be Done Before Selecting Immunotherapy in MPM (Slides Available)
10:05 - 10:20 | Author(s): Paul Baas
- Abstract
No abstract available for this presentation
-
+
DEBATE 1: PDL1 Testing and Tumor Mutation Burden Testing Should NOT be Done Before Selecting Immunotherapy in MPM (Slides Available)
10:20 - 10:35 | Author(s): Aaron Mansfield
- Abstract
No abstract available for this presentation
-
+
Radiation Session
- Type: Session
- Track:
- Presentations: 6
- Slides Available
- Moderators:Boris Sepesi
- Coordinates: 7/11/2019, 10:45 - 11:20, Westin New York at Times Square
-
+
New Developments in XRT: NCI-IASLC-MARF Radiation Guidelines (Slides Available)
10:45 - 10:55 | Author(s): Andreas Rimner
- Abstract
No abstract available for this presentation
-
+
SMART Neoadjuvant Therapy (Slides Available)
10:55 - 11:00 | Author(s): Marc de Perrot
- Abstract
No abstract available for this presentation
-
+
XRT Adjuvant Pembrolizumab (Slides Available)
11:00 - 11:05 | Author(s): Daniel Gomez
- Abstract
No abstract available for this presentation
-
+
Tumor Treating Fields (Slides Available)
11:05 - 11:10 | Author(s): Giovanni Luca Ceresoli
- Abstract
No abstract available for this presentation
-
+
IMRT Canada (Slides Available)
11:10 - 11:15 | Author(s): Marc de Perrot
- Abstract
No abstract available for this presentation
-
+
Accelerated Hypofractionated XRT (Slides Available)
11:15 - 11:20 | Author(s): Saumil Gandhi
- Abstract
No abstract available for this presentation
-
+
DNA Repair Session
- Type: Session
- Track:
- Presentations: 6
- Slides Available
- Moderators:Isabelle Opitz
- Coordinates: 7/11/2019, 11:35 - 12:10, Westin New York at Times Square
-
+
Science (Slides Available)
11:35 - 11:45 | Author(s): Dean Fennell
- Abstract
No abstract available for this presentation
-
+
CDK4/6 Abemaciclib (Slides Available)
11:45 - 11:50 | Author(s): Ibiayi Dagogo-Jack
- Abstract
No abstract available for this presentation
-
+
PARP Inhibitors (Slides Available)
11:50 - 11:55 | Author(s): Raffit Hassan
- Abstract
No abstract available for this presentation
-
+
Aurora Kinase Inhibitor (alisertib) (Slides Available)
11:55 - 12:00 | Author(s): Anne Tsao
- Abstract
No abstract available for this presentation
-
+
Wee1 (Slides Available)
12:00 - 12:05 | Author(s): Ravi Salgia
- Abstract
No abstract available for this presentation
-
+
TRC102 (Slides Available)
12:05 - 12:10 | Author(s): Joel Neal
- Abstract
No abstract available for this presentation
-
+
Anti-Metabolites and Chemotherapy
- Type: Session
- Track:
- Presentations: 3
- Slides Available
- Moderators:Giovanni Luca Ceresoli
- Coordinates: 7/11/2019, 13:55 - 14:15, Westin New York at Times Square
-
+
Science of Arginine Deprivation (Slides Available)
13:55 - 14:05 | Author(s): Peter Szlosarek
- Abstract
No abstract available for this presentation
-
+
ADI-PEG20 + Atezolizumab (Slides Available)
14:05 - 14:10 | Author(s): Peter Szlosarek
- Abstract
No abstract available for this presentation
-
+
Maintenance Pemetrexed (Slides Available)
14:10 - 14:15 | Author(s): Arkadiusz Dudek
- Abstract
No abstract available for this presentation
-
+
Miscellaneous Session
- Type: Session
- Track:
- Presentations: 11
- Slides Available
- Moderators:Joachim Aerts
- Coordinates: 7/11/2019, 14:25 - 15:25, Westin New York at Times Square
-
+
Brentuximab (Slides Available)
14:25 - 14:30 | Author(s): Anne Tsao
- Abstract
No abstract available for this presentation
-
+
Tazemetostat (Slides Available)
14:30 - 14:35 | Author(s): Marjorie Zauderer
- Abstract
No abstract available for this presentation
-
+
Cullen Neddylation Inhibitor (Pevonedistat - MLN4924, TAK924) (Slides Available)
14:40 - 14:45 | Author(s): Marjorie Zauderer
- Abstract
No abstract available for this presentation
-
+
343EphB4 & Recombinant EphB4-HSA (Slides Available)
14:45 - 14:50 | Author(s): Ravi Salgia
- Abstract
No abstract available for this presentation
-
+
Glutaminase Inhibitor CB-839 (Slides Available)
14:50 - 14:55 | Author(s): Aaron Lisberg
- Abstract
No abstract available for this presentation
-
+
Fus-1 Nanoparticles (Slides Available)
14:55 - 15:00 | Author(s): Ibiayi Dagogo-Jack
- Abstract
No abstract available for this presentation
-
+
Trabectedin (ATREUS trial, NCT 02194231)P (Slides Available)
15:00 - 15:05 | Author(s): Diego Cortinovis
- Abstract
No abstract available for this presentation
-
+
Lurbinectedin (Slides Available)
15:05 - 15:10 | Author(s): Joachim Aerts
- Abstract
No abstract available for this presentation
-
+
YS110 (CD26) (Slides Available)
15:10 - 15:15 | Author(s): Joachim Aerts
- Abstract
No abstract available for this presentation
-
+
Ganetespib (Slides Available)
15:15 - 15:20 | Author(s): Dean Fennell
- Abstract
No abstract available for this presentation
-
+
FAK Inhibitors (Slides Available)
15:20 - 15:25 | Author(s): Dean Fennell
- Abstract
No abstract available for this presentation
-
+
DEBATE 2: Genomic Profiling
- Type: Session
- Track:
- Presentations: 2
- Slides Available
- Moderators:Michele Carbone
- Coordinates: 7/11/2019, 15:40 - 15:40, Westin New York at Times Square
-
+
DEBATE 2: Genomic Profiling SHOULD be SOC in MM (Slides Available)
15:00 - 15:15 | Author(s): Raphael Bueno
- Abstract
No abstract available for this presentation
-
+
DEBATE 2: Genomic Profiling Should NOT be SOC in MM (Slides Available)
15:15 - 15:30 | Author(s): Isabelle Opitz
- Abstract
No abstract available for this presentation
-
+
Mesothelin-Targeting Agents
- Type: Session
- Track:
- Presentations: 9
- Slides Available
- Moderators:Anna Nowak
- Coordinates: 7/11/2019, 16:25 - 17:15, Westin New York at Times Square
-
+
Science (Slides Available)
16:25 - 16:35 | Author(s): Raffit Hassan
- Abstract
No abstract available for this presentation
-
+
Amatuximab (Slides Available)
16:35 - 16:40 | Author(s): Hedy Lee Kindler
- Abstract
No abstract available for this presentation
-
+
ARTEMIS (Chemo-Amatuximab)
16:40 - 16:45 | Author(s): Hedy Lee Kindler
- Abstract
No abstract available for this presentation
-
+
Anetumab Ravtansine
16:45 - 16:50 | Author(s): Hedy Lee Kindler
- Abstract
No abstract available for this presentation
-
+
Listeria Mesothelin Vaccine CRS-207 (Slides Available)
16:50 - 16:55 | Author(s): Matthew Gubens
- Abstract
No abstract available for this presentation
-
+
CRS207 + Chemotherapy (Slides Available)
16:55 - 17:00 | Author(s): Antoinette Wozniak
- Abstract
No abstract available for this presentation
-
+
SS1P (Slides Available)
17:00 - 17:05 | Author(s): Giovanni Luca Ceresoli
- Abstract
No abstract available for this presentation
-
+
LMB-100 (Slides Available)
17:05 - 17:10 | Author(s): Raffit Hassan
- Abstract
No abstract available for this presentation
-
+
BMS-986148 (ADC) (Slides Available)
17:10 - 17:15 | Author(s): Aaron Mansfield
- Abstract
No abstract available for this presentation